News | December 13, 2022
Evonik invests in US based biopharma company ‘Allay Therapeutics’
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
This will dramatically improve timely intervention with the right experts thus ensuring significant improvement in patient’s condition management and health outcome
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Subscribe To Our Newsletter & Stay Updated
